Take a look at some of the biggest movers in the premarket:
CVS Health (CVS) – The drug store and pharmacy benefits management company earned $2.04 per share in the first quarter, above the consensus estimate of $1.72 a share. Revenue also came in above Wall Street forecasts. CVS saw higher sales at its stores, with customer traffic spurred by Covid-19 vaccination visits. CVS also raised its full-year forecast, and its shares rose 3% in the premarket.
iRobot (IRBT) – iRobot earned 41 cents per share during the first quarter, compared to a consensus estimate of 9 cents a share. The maker of the Roomba robotic vacuum's revenue exceeded estimates as well, however the stock tumbled 8.6% in the premarket on concerns about shipping and component costs.
Get a weekly recap of the latest San Francisco Bay Area housing news. Sign up for NBC Bay Area’s Housing Deconstructed newsletter.
Pfizer (PFE) – The drugmaker beat estimates by 16 cents a share, with quarterly profit of 93 cents per share. Revenue also came in above forecasts and the company raised its full-year guidance as sales of its Covid-19 vaccine continue to be stronger than expected. Additionally, the Food and Drug Administration is set to authorize the vaccine for use in adolescents aged 12-15, according to federal officials familiar with the plan who spoke to The New York Times. Pfizer shares added 1.3% in premarket trading.
Vaxart (VXRT) – Vaxart surged 18.6% in premarket trading after it reported positive results in a phase 1 trial of its oral Covid-19 vaccine. Vaxart said the vaccine could be just as effective as the injected vaccines developed by Pfizer and Moderna (MRNA).
Under Armour (UAA) – The athletic apparel maker's stock climbed 2.8% in premarket action after it reported first-quarter profit of 16 cents per share, well above the 3 cents a share consensus estimate. Revenue also topped analysts' forecasts and Under Armour raised its full-year outlook as reopening markets spur demand for shoes and apparel. Separately, the company agreed to pay $9 million to settle a Securities and Exchange Commission probe into its accounting.
DuPont (DD) – The industrial materials maker reported quarterly profit of 91 cents per share, 15 cents a share above estimates. Revenue also topped analysts' forecasts. DuPont is seeing strong demand for its products from semiconductor makers as well as automobile markets, and the company raised its full-year profit and revenue forecast.
XPO Logistics (XPO) – XPO reported quarterly earnings of $1.46 per share, well above the consensus estimate of 97 cents a share. The transportation company's revenue was also above Wall Street forecasts, reaching record levels in sharp contrast to usual seasonal trends. XPO also raised its full-year forecast, but its shares lost 1.2% in premarket action.
Avis Budget (CAR) – Avis Budget lost 46 cents per share for the first quarter, smaller than the loss of $2.16 a share predicted by analysts. The car rental company's revenue beat Wall Street forecasts as well amid a jump in demand and more solid pricing for car rentals. The stock fell 1.4% in premarket action despite the upbeat results.
Qiagen (QGEN) – Qiagen reported better-than-expected earnings and sales for its latest quarter, as the genetic testing company saw increasing demand for non-coronavirus products as well as strength in its Covid-19 testing business.
SmileDirectClub (SDC) – SmileDirectClub said its current-quarter sales will be hurt by an April cyberattack, costing it between $10 million and $15 million. The maker of teeth-straightening systems said it successfully blocked the attack and restored its systems to normal. The stock lost 9.2% in the premarket. (Disclosure: NBC Nightly News investigated SmileDirectClub's customer complaints in February. The company accused NBCUniversal of publishing false information about the company and is seeking $2.85 billion for defamation.)
Domtar (UFS) – Domtar shares soared 16.1% in premarket action following a Bloomberg report that said Canada's Paper Excellence is exploring a deal to buy its U.S.-based paper and packaging rival. A deal could value Domtar in the mid-$50 per share range, compared to Monday's close of $40.52 a share.